These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27163830)

  • 21. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.
    Decensi A; Omodei U; Robertson C; Bonanni B; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Mora S; Sandri MT; Cazzaniga M; Franchi M; Pecorelli S
    Circulation; 2002 Sep; 106(10):1224-8. PubMed ID: 12208797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural aspects of the postmenopausal endometrium after oral or transdermal estrogen administration.
    Baracat EC; Simões MJ; Soares JM; Haidar MA; Rodrigues de Lima G
    Clin Exp Obstet Gynecol; 2001; 28(1):26-30. PubMed ID: 11332584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women.
    Farr JN; Khosla S; Miyabara Y; Miller VM; Kearns AE
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E249-57. PubMed ID: 23322818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
    Yilmazer M; Fenkci V; Fenkci S; Sonmezer M; Aktepe O; Altindis M; Kurtay G
    Maturitas; 2003 Dec; 46(4):245-53. PubMed ID: 14625121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.
    Asthana S; Craft S; Baker LD; Raskind MA; Birnbaum RS; Lofgreen CP; Veith RC; Plymate SR
    Psychoneuroendocrinology; 1999 Aug; 24(6):657-77. PubMed ID: 10399774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial.
    Wharton W; Baker LD; Gleason CE; Dowling M; Barnet JH; Johnson S; Carlsson C; Craft S; Asthana S
    J Alzheimers Dis; 2011; 26(3):495-505. PubMed ID: 21694454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
    Reginster JY; Christiansen C; Dequinze B; Deroisy R; Gaspard U; Taquet AN; Franchimont P
    Calcif Tissue Int; 1993 Jul; 53(1):13-6. PubMed ID: 8394191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of SULT1A1 genetic variation on age at menopause, estrogen levels, and response to hormone therapy in recently postmenopausal white women.
    Moyer AM; de Andrade M; Weinshilboum RM; Miller VM
    Menopause; 2016 Aug; 23(8):863-9. PubMed ID: 27300114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women.
    Ossewaarde ME; Bots ML; Bak AA; Van Der Schouw YT; Witteman JC; Planellas J; Bennink HJ; Grobbee DE
    Maturitas; 2001 Sep; 39(3):209-16. PubMed ID: 11574180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition.
    Wharton W; Gleason CE; Dowling NM; Carlsson CM; Brinton EA; Santoro MN; Neal-Perry G; Taylor H; Naftolin F; Lobo RA; Merriam G; Manson JE; Cedars MI; Miller VM; Black DM; Budoff M; Hodis HN; Harman SM; Asthana S
    J Alzheimers Dis; 2014; 40(2):331-41. PubMed ID: 24430001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis.
    Henderson VW; St John JA; Hodis HN; McCleary CA; Stanczyk FZ; Shoupe D; Kono N; Dustin L; Allayee H; Mack WJ
    Neurology; 2016 Aug; 87(7):699-708. PubMed ID: 27421538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
    Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS
    JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study.
    Baker LD; Sambamurti K; Craft S; Cherrier M; Raskind MA; Stanczyk FZ; Plymate SR; Asthana S
    Am J Geriatr Psychiatry; 2003; 11(2):239-44. PubMed ID: 12611754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Alora Study Group.
    Good WR; John VA; Ramirez M; Higgins JE
    Climacteric; 1999 Mar; 2(1):29-36. PubMed ID: 11915854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial.
    El Khoudary SR; Zhao Q; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman SM; Cedars MI; Hopkins PN; Kearns AE; Miller VM; Taylor HS; Budoff MJ
    J Am Heart Assoc; 2019 Aug; 8(15):e012763. PubMed ID: 31652073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive response to estradiol in postmenopausal women is modified by high cortisol.
    Baker LD; Asthana S; Cholerton BA; Wilkinson CW; Plymate SR; Green PS; Merriam GR; Fishel MA; Watson GS; Cherrier MM; Kletke ML; Mehta PD; Craft S
    Neurobiol Aging; 2012 Apr; 33(4):829.e9-20. PubMed ID: 21855173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differing effects of oral conjugated equine estrogen and transdermal estradiol on vitamin D metabolism in postmenopausal women: a 4-year longitudinal study.
    Santoro AM; Simpson CA; Cong E; Haas A; Sullivan RR; Parziale S; Deng Y; Insogna KL
    Menopause; 2022 Oct; 29(10):1200-1203. PubMed ID: 35969885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
    Bhavnani BR
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.